Literature DB >> 2091018

The risks of handling cytotoxic drugs. II. Recommendations for working with cytotoxic drugs.

G P Kaijser1, W J Underberg, J H Beijnen.   

Abstract

Presuming that preparation of antineoplastic drugs without proper protection may lead to mutagenic urine (of which the effects are uncertain), one has to take great care when preparing these drugs. Apart from Norway no other country has national regulations issued by the government for handling cytostatic agents. Many organizations in various countries have made their own guidelines, which may be adapted to the situations in local hospitals. The following recommendations have been compiled after a review of the literature. They reflect a personal set of guidelines for preparation, administration and disposal of cytotoxic drugs. They are probably the minimum precautions that should be taken, and have not been approved by any committee or agency. Further precautions must first have their potential benefit weighed against probable inconvenience and additional costs.

Mesh:

Substances:

Year:  1990        PMID: 2091018     DOI: 10.1007/BF01967822

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  90 in total

1.  Injectable-antineoplastic-drug practices in Michigan hospitals.

Authors:  I A Cohen; S J Newland; D M Kirking
Journal:  Am J Hosp Pharm       Date:  1987-05

2.  Purging procedure eliminates antineoplastic drug solution spillage.

Authors:  D L Barcon; C A Presant; J Melville
Journal:  Am J Hosp Pharm       Date:  1987-10

3.  Special considerations in the use of vertical laminar-flow workbenches.

Authors:  K E Avis; J W Levchuk
Journal:  Am J Hosp Pharm       Date:  1984-01

4.  Possible risk of working with antineoplastic drugs in horizontal laminar flow hoods.

Authors:  A L Donner
Journal:  Am J Hosp Pharm       Date:  1978-08

5.  Pharmaceutics: antineoplastic agents as potential carcinogens: are nurses and pharmacists at risk?

Authors:  S D Reich
Journal:  Cancer Nurs       Date:  1981-12       Impact factor: 2.592

6.  Precautionary measures in the preparation of antineoplastics.

Authors:  C F Ladik; G P Stoehr; M A Maurer
Journal:  Am J Hosp Pharm       Date:  1980-09

7.  An unusual accident during the administration of chemotherapy.

Authors:  E Duvall; B Baumann
Journal:  Cancer Nurs       Date:  1980-08       Impact factor: 2.592

8.  Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome.

Authors:  K Hemminki; P Kyyrönen; M L Lindbohm
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

9.  Risk of handling injectable antineoplastic agents.

Authors:  R W Anderson; W H Puckett; W J Dana; T V Nguyen; J C Theiss; T S Matney
Journal:  Am J Hosp Pharm       Date:  1982-11

10.  Permeability of four disposable protective-clothing materials to seven antineoplastic drugs.

Authors:  J L Laidlaw; T H Connor; J C Theiss; R W Anderson; T S Matney
Journal:  Am J Hosp Pharm       Date:  1985-11
View more
  4 in total

1.  Implementing a multiple-isolator unit for centralized preparation of cytotoxic drugs in a cancer center pharmacy.

Authors:  J L Cazin; P Gosselin
Journal:  Pharm World Sci       Date:  1999-08

Review 2.  The risks of handling cytotoxic drugs. I. Methods of testing exposure.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

3.  Centralized preparation of hazardous drugs. A choice between isolator and laminar airflow.

Authors:  P Larrouturou; J Huchet; M C Taugourdeau
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

4.  Detection of contamination with antineoplastic agents in a hospital pharmacy department.

Authors:  P J Sessink; R B Anzion; P H Van den Broek; R P Bos
Journal:  Pharm Weekbl Sci       Date:  1992-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.